Schematic of traditional and non-traditional risk factors that account for the greatly increased risk of macrovascular disease in people with DKD. CRP,

Slides:



Advertisements
Similar presentations
Professor Abdus Samad MD FACC Karachi Institute of Heart Diseases Karachi, Pakistan May 1, 2010.
Advertisements

UKPDS Paper 35 Slides © University of Oxford Diabetes Trials Unit
Canadian Diabetes Association Clinical Practice Guidelines Screening for the Presence of Coronary Artery Disease Chapter 23 Paul Poirier, Robert Dufour,
Pravastatin in Elderly Individuals at Risk of Vascular Disease Presented at Late Breaking Clinical Trials AHA 2002 PROSPER.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Aspirin for the Prevention of Cardiovascular Events.
Date of download: 6/3/2016 From: Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Practice-Level Variation in Inappropriate.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Has Public Reporting of Hospital Readmission Rates.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Procedural Outcomes of Chronic Total Occlusion Percutaneous.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Application of the Screening for Heart Attack Prevention.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.
BDNF: brain-derived neurotrophic factor CRP: C-reactive protein
Copyright © 2014 American Medical Association. All rights reserved.
Elevated Circulating Levels of Inflammatory Markers in
Copyright © 2004 American Medical Association. All rights reserved.
Pravastatin in Elderly Individuals at Risk of Vascular Disease
ELIGIBILITY: MRC/BHF Heart Protection Study
CANTOS: The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study
First time a CETP inhibitor shows reduction of serious CV events
Pathologic Findings 12/18/07
Neil J. Stone et al. JACC 2014;63:
The challenge of achieving 1% operative mortality for coronary artery bypass grafting: A multi-institution Society of Thoracic Surgeons Database analysis 
Concomitant coronary and peripheral arterial disease: Relationship between the inflammatory status of the affected limb and the severity of coronary artery.
بسم الله الرحمن الرحيم الموضوع:الوضوء صفته وفرائضه وسننه
Volume 10, Issue 10, Pages (October 2013)
Volume 10, Issue 10, Pages (October 2013)
Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)
Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease 
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and.
Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease 
Understanding PAD.
Todd A. Lee, PharmD, PhD, Brian Bartle, MPH, Kevin B. Weiss, MD, MPH 
Volume 79, Issue 2, Pages (January 2011)
Volume 155, Issue 2, Pages e2 (August 2018)
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and.
Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease  Scott E. Musicant, MD,
Quantitating the Dose of Physical Activity in Secondary Prevention: Relation of Exercise Intensity to Survival  Barry A. Franklin, PhD  Mayo Clinic Proceedings 
Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit  Barry A. Franklin, PhD  Mayo.
OR (95% CI) for CHD associated with inflammatory markers before and after adjustment for established risk factors. OR (95% CI) for CHD associated with.
P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.
Coronary artery bypass grafting in diabetics: A growing health care cost crisis  Sajjad Raza, MD, Joseph F. Sabik, MD, Ponnuthurai Ainkaran, MS, Eugene.
Effect of Ma-Pi diet versus control diet on change in TNF-α, IL-6, CRP, BAP test, and IGF-1. Effect of Ma-Pi diet versus control diet on change in TNF-α,
OR (95% CI) for CHD associated with inflammatory markers in all participants and in subsets of non-users of statins or non-users of aspirin therapy. OR.
On Statin Treatment to Prevent Sepsis in Dialysis Patients
Volume 68, Issue 1, Pages (July 2005)
Prevalence of microvascular and macrovascular complications compared between cohort 1 and cohort 2 for subjects with type 2 (A, upper panel) and type 1.
Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)
MATCH Results: Implications for the Internist
Schematic of screening program for diabetes mellitus (DM) during acute myocardial infarction (AMI). Schematic of screening program for diabetes mellitus.
Correlation between plasma C reactive protein (CRP) and angiopoietin-like protein 4 (ANGPTL4). Correlation between plasma C reactive protein (CRP) and.
(A) Serum CRP levels. (A) Serum CRP levels. T2DM: n=6 per group. *p
Figure 2. Odds ratios (ORs) from the multivariate logistic regression analysis and hazard ratios (HRs) from the Cox regression analysis Odds ratios (ORs)
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Schematic overview of diabetes-associated microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular (cerebrovascular, coronary artery,
Prevalence of clinically significant microvascular (green) and clinically significant macrovascular (yellow) disease alone and combined microvascular and.
Genetic predisposition to CHD modifies the increased CHD risk associated with smoking (*) ORs adjusted for age, gender, total energy intake, alcohol intake,
Health profile used in workshops to help people make diabetes management decisions. Health profile used in workshops to help people make diabetes management.
Prasugrel versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.
Several genetic, environmental, lipid partitioning, and biochemical factors, shown on the left, promote the development of subclinical inflammation and.
Emily Spangler, Robert W. Chang, Philip P. Goodney 
Baseline characteristics of the participants according to study group.
Schematic of the relationship between smoking and legume consumption (smoking–diet relationship) in relation to pulmonary inflammation, systemic inflammation,
FFR guided deferral of PCI in patients with ACS and stable coronary artery disease (SCAD). FFR guided deferral of PCI in patients with ACS and stable coronary.
Percent of patients with ASDAS inactive disease grouped by normal or elevated CRP at baseline through week 156. §p
Relationship between updated systolic blood pressure (SBP), right, and updated HbA1c, left, and the incidence of microvascular complications (closed symbols)
Traditional cardiovascular risk factors can cause cardiac disease in patients with IIM. Systemic and local inflammation may either have a direct effect.
Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.
Temporal profiles of C-reactive protein (CRP), interleukin 6 (IL-6) and interleukin 1 receptor antagonist (IL-1Ra) after subarachnoid hemorrhage plotted.
Presentation transcript:

Schematic of traditional and non-traditional risk factors that account for the greatly increased risk of macrovascular disease in people with DKD. CRP, C-reactive protein; IL-6, interleukin 6; MI, myocardial infarction; PAD, peripheral artery disease. Schematic of traditional and non-traditional risk factors that account for the greatly increased risk of macrovascular disease in people with DKD. CRP, C-reactive protein; IL-6, interleukin 6; MI, myocardial infarction; PAD, peripheral artery disease. Koyal Jain, and Amy K. Mottl Diabetes Spectr 2015;28:187-192 ©2015 by American Diabetes Association